The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intensified hormonal blockade with SBRT in PSMA-PET detected oligometastatic prostate adenocarcinoma: Results from the phase II Metacure trial cohorts B2 and the B2 expansion.
 
Eric Bent
Stock and Other Ownership Interests - Unity Biotechnology
 
Sean McBride
Consulting or Advisory Role - Janssen
Research Funding - Genentech
 
Shilpa Gupta
Stock and Other Ownership Interests - BioNTech SE; Moderna Therapeutics; Nektar
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb/Medarex; Foundation Medicine; Genzyme; Gilead Sciences; Merck; Natera; Pfizer; Seagen
Speakers' Bureau - Bristol-Myers Squibb; Gilead Sciences; Seagen
Research Funding - Bristol Myers Squibb Foundation (Inst); EMD Serono (Inst); Exelixis (Inst); Gilead Sciences (Inst); Merck (Inst); Moderna Therapeutics (Inst); Novartis (Inst); QED Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst); Tyra Biosciences (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate author royalty
Travel, Accommodations, Expenses - Pfizer
 
David VanderWeele
Honoraria - Astellas Pharma; Myovant Sciences
Consulting or Advisory Role - Bayer; Janssen
Research Funding - Arcus Biosciences (Inst); AstraZeneca (Inst); Bayer (Inst); Curium Pharma (Inst); Fortis (Inst); Harpoon therapeutics (Inst); Janssen Oncology (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
 
Russell Szmulewitz
Consulting or Advisory Role - Amgen; Bayer; Eisai; Janssen Oncology; Merck; Novartis; Sanofi
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bayer (Inst); Janssen Oncology (Inst); Janux Therapeutics (Inst); Merck (Inst); Novartis (Inst); Nurix (Inst); Progenics (Inst)
Patents, Royalties, Other Intellectual Property - Patent licensed by University of Chicago of which I am co-inventor to Corcept Therapeutics for combination AR/GR inhibition in prostate cancer
Travel, Accommodations, Expenses - DAVA Oncology
 
Matthew Dallos
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Sanofi
 
Glenn Bubley
No Relationships to Disclose
 
Anuradha Gopalan
No Relationships to Disclose
 
Alicia Morgans
Stock and Other Ownership Interests - Vertex (I)
Honoraria - Advanced Accelerator Applications; Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Curium Pharma; Exelixis; Janssen; Janssen Oncology; Macrogenics; Merck; Myovant Sciences; Pfizer; Sanofi; Telix Pharmaceuticals
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; Exelixis; Janssen; Lantheus Medical Imaging; Merck; Myovant Sciences; Myovant Sciences; Myriad Genetics; Novartis; Sanofi
Research Funding - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Dendreon; Genentech; Myovant Sciences; Pfizer; Sanofi; Seattle Genetics/Astellas
Travel, Accommodations, Expenses - Sanofi; Telix Pharmaceuticals
 
Stanley Liauw
Stock and Other Ownership Interests - Novo Nordisk
 
Elyn Riedel
No Relationships to Disclose
 
Paul Nguyen
Stock and Other Ownership Interests - Nanocan Therapeutics; Reversal Therapeutics; Stratagen Bio; Telerad Oncology; Volatilyx (I)
Consulting or Advisory Role - AIQ Solutions; Bayer; Blue Earth Diagnostics; Boston Scientific; Janssen Oncology; Myovant Sciences; Nanocan Therapeutics; Novartis; Theranano
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I)
 
Min Yuen Teo
Consulting or Advisory Role - AstraZeneca; Janssen Oncology
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Pharmacyclics (Inst)
 
Mary-Ellen Taplin
Honoraria - Astellas Pharma; AstraZeneca; Blue Earth Diagnostics; Carden Jennings; Clovis Oncology; DAVA Pharmaceuticals; Flare Therapeutics; Interpublic GIS; Janssen-Ortho; MJH Healthcare Holdings, LLC; Novartis; Pfizer; Physicans' Education Resource; Propella Therapeutics; Research to Practice; UpToDate
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Blue Earth Diagnostics; Flare Therapeutics; Geode Therapeutics; Janssen-Ortho; Laekena; Novartis; Pfizer; Propella Therapeutics; UpToDate
Research Funding - Janssen-Ortho (Inst)
Travel, Accommodations, Expenses - Advanced Prostate Cancer Society; Prostate Cancer Foundation; South West Prostate Cancer Symposium
 
Howard Scher
Honoraria - Physicans' Education Resource
Consulting or Advisory Role - AIQ Global; Bayer; Genzyme; Janssen Research & Development; Novartis; Pfizer; Promontory Therapeutics; Regeneron; WIRB-Copernicus Group
Research Funding - AIQ Solutions (Inst); Astrin Biosciences (Inst); Biodesix (Inst); Janssen (Inst)
Patents, Royalties, Other Intellectual Property - Elucida Oncology - Intellectual Property Rights
Travel, Accommodations, Expenses - Bayer; Biodesix; Epic Sciences; Promontory Therapeutics; Prostate Cancer Foundation; WIRB-Copernicus Group